Ra Pharmaceuticals Receives $58,500,000 Series B Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=14ce04a1-2418-49f2-be10-ff6c82b16b63
Date 7/23/2015
Company Name Ra Pharmaceuticals
Mailing Address One Kendall Square Cambridge, MA 02139 USA
Company Description Ra Pharmaceuticals is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma’s peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability.
Proceeds Purposes The proceeds of the financing will be used to generate human proof of concept data for its lead molecule, RA101495, in multiple indications.